Early findings in a pilot study of anterior cervical interbody fusion in which recombinant human bone morphogenetic protein–2 was used with poly(L-lactide-co-D,L-lactide) bioabsorbable implants

Abstract

The results in this series indicate that the use of Cornerstone-HSR as a bioabsorbable interbody spacer in combination with Infuse bone graft may be an alternative treatment for cervical spine fusion.